Events - This Week

DHAKAINS: Quarterly Earnings Q2 | DHAKAINS 
02 Aug 2026

(Q2 Un-audited): EPS was Tk. 0.67 for April-June 2026 as against Tk. 0.73 for April-June 2025; EPS was Tk. 1.20 for January-June 2026 as against Tk. 1.23 for January-June 2025. NOCFPS was Tk. (0.20) for January-June 2026 as against Tk. (0.54) for January-June 2025. NAV per share (with revaluation) was Tk. 37.87 as on June 30, 2026 and Tk. 36.70 as on December 31, 2025. NAV per share (without revaluation) was Tk. 27.23 as on June 30, 2026 and Tk. 26.06 as on December 31, 2025.

PREMIERLEA: Quarterly Earnings Q1 | PREMIERLEA 
02 Aug 2026

(Q1 Un-audited): Consolidated EPS was Tk. (1.80) for January-March 2026 as against Tk. (1.77) for January-March 2025. Consolidated NOCFPS was Tk. 0.02 for January-March 2026 as against Tk. 0.85 for January-March 2025. Consolidated NAV per share was Tk. (98.08) as on March 31, 2026 and Tk. (76.05) as on March 31, 2025.

PREMIERLEA: Dividend | PREMIERLEA 
02 Aug 2026

The Board of Directors has recommended No Dividend for the year ended December 31, 2025. Date of AGM: 17.09.2026, Time: 11:00 AM, Venue: New Sindurpur Hall (4th Floor), FARS Hotel & Resorts, 212, Shahid Syed Nazrul Islam Sharani, Purana Paltan, Dhaka-1000. The AGM will be held through Hybrid System in combination of Physical presence of Shareholders at the Venue and presence or connection of Shareholders through Digital Platform. Record Date: 23.08.2026. The Company has also reported Consolidated EPS of Tk. (21.98), Consolidated NAV per share of Tk. (96.38) and Consolidated NOCFPS of Tk. 14.97 for the year ended December 31, 2025 as against Tk. (27.50), Tk. (74.36) and Tk. 22.92 respectively for the year ended December 31, 2024. (end)

PRIMEBANK: Quarterly Earnings Q2 | PRIMEBANK 
02 Aug 2026

(Q2 Un-audited): Consolidated EPS was Tk. 1.85 for April-June 2026 as against Tk. 1.64 (Restated) for April-June 2025; Consolidated EPS was Tk. 3.56 for January-June 2026 as against Tk. 3.36 (Restated) for January-June 2025. Consolidated NOCFPS was Tk. 7.55 for January-June 2026 as against Tk. 16.29 (Restated) for January-June 2025. Consolidated NAV per share was Tk. 39.03 as on June 30, 2026 and Tk. 33.61 (Restated) as on June 30, 2025. (cont.)

RELIANCINS: Quarterly Earnings Q2 | RELIANCINS 
02 Aug 2026

(Q2 Un-audited): EPS was Tk. 3.64 for April-June 2026 as against Tk. 3.12 for April-June 2025; EPS was Tk. 6.52 for January-June 2026 as against Tk. 5.39 for January-June 2025. NOCFPS was Tk. 9.38 for January-June 2026 as against Tk. 16.74 for January-June 2025. NAV per share was Tk. 84.68 as on June 30, 2026 and Tk. 78.95 as on December 31, 2025. Reasons for Deviation: EPS increased due to increase in underwriting income and investment income. NOCFPS decreased due to reinsurance and claim payment. NAVPS increased due to increase in retained earnings and fair value of shares (end)

JANATAINS: Quarterly Earnings Q2 | JANATAINS 
02 Aug 2026

(Q2 Un-audited): EPS was Tk. 0.80 for January-June 2026 as against Tk. 0.74 for January-June 2025. NOCFPS was Tk. 0.34 for January-June 2026 as against Tk. 0.64 for January-June 2025. NAV per share was Tk. 15.93 as on June 30, 2026 and Tk. 15.07 as on December 31, 2025.

MEGHNALIFE: Quarterly Earnings Q2 | MEGHNALIFE 
02 Aug 2026

(Q2 Un-audited): As per life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 75.31 million as against excess of total income over total expenses including claims (surplus) of BDT 64.48 million in the corresponding previous period of 2025. Balance of Life Insurance Fund was BDT 15,200.69 million as on June 30, 2026 as against BDT 15,337.49 million as on June 30, 2025. NOCFPS was Tk. (14.16) as on June 30, 2026 as against Tk. (15.77) as on June 30, 2025. (end)

REPUBLIC: Quarterly Earnings Q2 | REPUBLIC 
02 Aug 2026

(Q2 Un-audited): EPS was Tk. 0.54 for April-June 2026 as against Tk. 0.63 for April-June 2025; EPS was Tk. 1.09 for January-June 2026 as against Tk. 1.07 for January-June 2025. NOCFPS was Tk. (0.32) for January-June 2026 as against Tk. 0.03 for January-June 2025. NAV per share was Tk. 19.77 as on June 30, 2026 and Tk. 19.70 as on December 31, 2025.

MERCANBANK: Quarterly Earnings Q2 | MERCANBANK 
02 Aug 2026

(Q2 Un-audited): Consolidated EPS was Tk. (0.07) for April-June 2026 as against Tk. 0.98 for April-June 2025; Consolidated EPS was Tk. 0.22 for January-June 2026 as against Tk. 1.82 for January-June 2025. Consolidated NOCFPS was Tk. 0.74 for January-June 2026 as against Tk. 3.60 for January-June 2025. Consolidated NAV per share was Tk. 24.30 as on June 30, 2026 and Tk. 24.35 as on December 31, 2025. Reasons for deviation: Net Asset Value per share (NAVPS) reduced compared to previous period due to the decrease of total shareholders' Equity. Earnings Per Share (EPS) reduced compared to previous period due to the decrease of Profit before provision. Net Operating Cash Flow Per Share (NOCFPS) has decreased compared to the previous period due to a decrease in Net Cash flows from Operating activities. (end)

SONALILIFE: Quarterly Earnings Q2 | SONALILIFE 
02 Aug 2026

(Q2 Audited): As per life revenue account of the company for April to June, 2026, excess of total income over total expenses including claims (surplus) was BDT 224.2 million as against excess of total income over total expenses including claims (surplus) of BDT 441.98 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to June, 2026, excess of total income over total expenses including claims (surplus) was BDT 336.91 million as against excess of total income over total expenses including claims (surplus) of BDT 725.77 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT 9,296.39 million as on June 30, 2026 as against BDT 8,777.99 million as on June 30, 2025 resulting a net increase of BDT 518.4 million. NOCFPS was Tk. (2.68) for January-June 2026 as against Tk. 2.99 for January-June 2025. (end)

PADMALIFE: Spot for AGM | PADMALIFE 
02 Aug 2026 - 04 Aug 2026

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 02.08.2026 to 04.08.2026 and trading of the shares will remain suspended on record date i.e., 06.08.2026.

SONALILIFE: Record Date for AGM | SONALILIFE 
02 Aug 2026

The Board of Directors has recommended 15% Cash Dividend for the year ended December 31, 2025. Date of AGM: August 27, 2026, at 10.00 A.M., Venue: (Hybrid System) Conference Room (5th Floor) SLICL, 68/B, DIT Road, Malibagh Chowdhury Para. Record Date: August 02, 2026. The Company has also reported EPS of Tk. 1.62, NAV per share of Tk. 32.15 and NOCFPS of Tk. 11.81 for the year ended December 31, 2025 as against Tk. 1.73, Tk. 39.64 and Tk. 17.37 respectively for the year ended December 31, 2024.

BXPHARMA: Record Date for AGM | BXPHARMA 
02 Aug 2026

The Board of Directors has recommended 47.5% Cash Dividend for the year ended June 30, 2025. Date & Time of AGM: The Annual General Meeting (AGM) will be convened at the earliest practicable time, subject to obtaining the necessary permission and condonation of delay from the Hon'ble High Court Division of the Supreme Court of Bangladesh. Record Date: 02.08.2026. The Company has also reported Consolidated EPS of Tk. 15.56, Consolidated NAV per share of Tk. 119.04, and Consolidated NOCFPS of Tk. 16.19 for the year ended June 30, 2025, as against Tk. 13.07, Tk. 107.48, and Tk. 18.75 respectively for the year ended June 30, 2024. (end)

UCB: Spot for Rights Issue | UCB 
30 Jul 2026 - 03 Aug 2026

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 30.07.2026 to 03.08.2026 and trading of the shares will remain suspended on record date i.e., 04.08.2026 for determination of entitlement of Rights Issue.